Participants were tested using a Mini Mental State Examination to test their level of cognitive ability and see if they qualified as a demented patient to be included in the study.
2.
The study found an improvement in cognitive function from the CST treatment, as measured by the Mini Mental State Examination ( MMSE ) and the Alzheimer s Disease Assessment Scale ( ADAS-Cog ), as well as an improvement in quality of life self-reported by the participants using the Quality of Life-AD measure.